SOURCE: Vascular Pathways, Inc.

Vascular Pathways

November 19, 2014 08:00 ET

Vascular Pathways Names Rudy Mazzocchi Executive Chairman

BOCA RATON, FL--(Marketwired - November 19, 2014) - Vascular Pathways, Inc., a privately held medical device manufacturer with innovative wire-guided technology for peripheral intravascular access, today announced the company has appointed Rudy Mazzocchi as Executive Chairman of their Board of Directors.

 "We are extremely excited to announce the appointment of Rudy Mazzocchi as Executive Chairman," said Vascular Pathways' President and CEO Bill Bold. "Rudy brings strong leadership, important insights, and a proven track record of success in the medical device industry to the Vascular Pathways Team."

"It's a privilege to be part of this Amir Belson Company which provides an elegant, novel technology that can impact such a large and well-established market," commented Mazzocchi. "Together, with the solid backing of a strong venture capital syndicate, a stellar management team, and a thoughtful, engaged Board of Directors, this company is destined for great things!"

Rudy Mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Authoring over 50 patents, he has been influential in pioneering new companies involved in cardiology, oncology, orthopedics, neurosurgery, ophthalmology and even embryonic stem-cell development. Through these efforts, he has become the recipient of many technology and business awards, including the Ernst & Young Entrepreneur of the Year Award in Healthcare (2004), Businessman of the Year Award (2005), and Global Entrepreneur of the Year Award (2013).

Rudy currently serves as CEO of ELENZA (an Implantable Electro-active Intraocular Lens technology) and previously served as the Interim-CEO of NovaVision Inc. (a Vision Restoration Therapy Company). He was the Managing Director of Accutive Medical Ventures & The Innovation Factory. He is also the former Co-founder and CEO of Image-Guided NEUROLOGICS, a company acquired by Medtronic in 2005. His career includes other founding and directorship roles at numerous start-up medical companies including MICROVENA (former eV3), Vascular Science, CytoGenesis, and Thermonix, and is the award-winning author of The Equity Series and Storytelling - The Indispensable Art of Entrepreneurism; (

About Vascular Pathways, Inc.

Founded in 2005, by Amir Belson, M.D., Vascular Pathways is a medical device company commercializing the AccuCath® IV Catheter System Line, an FDA cleared, guidewire catheter system enabling rapid, safe, and successful IV insertion. Vascular Pathways, Inc. is privately held by CHL Medical Partners, Ascension Health Ventures, and MVM Life Sciences. For further information about Vascular Pathways or the AccuCath® IV catheter line, please visit or call 844-VASPATH.

Contact Information